Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Cancers · 15.01.2023 · 15 (2) · 533
DOI: 10.3390/cancers15020533 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.01.2023. Verfasst von Chen Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. Die Arbeit wurde bisher 160-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Post-Doctor Research Project, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) remains a global health challenge, causing 600,000 deaths each year. Infectious factors, including hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV), have long been considered the major risk factors for the development and progression of HCC. These pathogens induce hepatocyte transformation through a variety of mechanisms, including insertional mutations caused by viral gene integration, epigenetic changes, and the induction of long-term immune dysfunction. The discovery of these mechanisms, while advancing our understanding of the disease, also provides targets for new diagnostic and therapeutic approaches. In addition, the discovery and research of chronic HEV infection over the past decade indicate that this common hepatitis virus also seems to have the potential to induce HCC. In this review, we provide an overview of recent studies on the link between hepatitis virus and HCC, as well as new diagnostic and therapeutic approaches to HCC based on these findings. Finally, we also discuss the potential relationship between HEV and HCC. In conclusion, these associations will further optimize the diagnosis and treatment of infection-associated HCC and call for better management policies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Post-Doctor Research Project, West China Hospital, Sichuan University
- Key R&D Program of Sichuan Provincial Department of Science and Technology (Major Science and Technology Project)
- Sichuan University postdoctoral interdisciplinary Innovation Fund
- Key R&D Program of Sichuan Provincial Department of Science and Technology (Major Science and Technology Project)
Zitieren
APA
Shen, C., Jiang, X., Li, M., & Luo, Y. (2023). Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Cancers, 15(2), 533. https://doi.org/10.3390/cancers15020533
Vancouver
Shen C, Jiang X, Li M, Luo Y. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Cancers. 2023;15(2):533. doi:10.3390/cancers15020533
BibTeX
@article{Shen2023,
author = {Shen, Chen and Jiang, Xin and Li, Mei and Luo, Yao},
title = {Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances},
journal = {Cancers},
year = {2023},
volume = {15},
number = {2},
pages = {533},
doi = {10.3390/cancers15020533}
}
EUVIMED